Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Diabetes constituted the majority of indications (n = 16,863, 58.2%), followed by weight control (n = 1,352, 4.7%) and non-diabetic blood glucose abnormalities (n = 556, 1.9%)
Leave on briefly if tolerated
MOF-based platforms have offered high drug-loading capacity and specific therapeutic efficacy in cancer treatment through multimodal approaches, such as photodynamic, photothermal, and chemodynamic therapy
The role of Tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials
The Complex Interactions Between Obesity, Metabolism and the Brain
US$ 27.99
US$ 24.12
US$ 20.49
US$ 23.74
US$ 22.15
US$ 25.10
US$ 27.49
US$ 20.73
US$ 28.76
US$ 21.30
US$ 27.35
